Anglikang is a modern pharmaceutical company specializing in the health of Chinese people, featuring oral cephalosporins, cardiovascular and kidney diseases.
In the future development, Anglikang will adhere to the two-wheel drive of technological transformation and product innovation, and build the company into an innovative international enterprise with strong comprehensive competitiveness in the industry.
Anglikang always insists on technological innovation to drive enterprise development and continuously invests a large amount of research and development funds.